首页 | 本学科首页   官方微博 | 高级检索  
     

胞外信号调节激酶1/2通路在阿霉素引起的心肌细胞损伤中的作用
引用本文:张莉莉,赖东平,王秀玉,郑东诞,郭润民,沈宁,陈培熹,冯鉴强. 胞外信号调节激酶1/2通路在阿霉素引起的心肌细胞损伤中的作用[J]. 中国药理学通报, 2012, 28(7): 961-966
作者姓名:张莉莉  赖东平  王秀玉  郑东诞  郭润民  沈宁  陈培熹  冯鉴强
作者单位:1. 广东省医学科学院,广东省人民医院,广东省老年医学研究所综合科,广东,广州,510080
2. 江西省龙南县妇幼保健院内科,江西,龙南,341700
3. 中山大学中山医学院生理学教研室,广东,广州,510080
4. 中山大学附属第一医院黄埔院区心血管内科,广东,广州,510080
基金项目:广东省科技计划项目(No 2011B080701051,2010B080701105,2010B080701035,2010B080701015)
摘    要:目的探讨胞外信号调节激酶1/2(ERK 1/2)通路在阿霉素(doxorubicin,DOX)引起的心肌细胞损伤中的作用。方法应用DOX处理H9c2心肌细胞建立细胞损伤的体外模型,在DOX处理前应用ERK 1/2抑制剂PD98059抑制ERK 1/2的活化;检测细胞存活率、ERK 1/2的活化、胞内活性氧(ROS)水平、线粒体膜电位(MMP)以及胱硫醚γ-裂解酶(CSE,为内源性硫化氢的合成酶)的表达。结果 5μmol·L-1DOX处理H9c2心肌细胞1~6 h,呈时间依赖性地促进ERK1/2的活化;5μmol·L-1DOX对心肌细胞具有明显的损伤作用,表现为细胞存活率下降、ROS水平升高、MMP丢失及CSE表达降低;在DOX处理H9c2心肌细胞前30min,应用ERK1/2抑制剂10μmol·L-1PD-98059预处理能明显拮抗DOX对心肌细胞的损伤作用,使ROS水平降低,细胞存活率MMP和CSE表达水平均升高。结论 ERK1/2通路参与DOX对H9c2心肌细胞的损伤作用。

关 键 词:阿霉素  心肌毒性  H9c2心肌细胞  氧自由基  线粒体膜电位  胞外信号调节激酶1/2

Role of ERK1/2 pathway in doxorubicin-induced cardiomyocyte injury
ZHANG Li-li , LAI Dong-ping , WANG Xiu-yu , ZHENG Dong-dan , GUO Run-min , SHEN Ning , CHEN Pei-xi , FENG Jian-qiang. Role of ERK1/2 pathway in doxorubicin-induced cardiomyocyte injury[J]. Chinese Pharmacological Bulletin, 2012, 28(7): 961-966
Authors:ZHANG Li-li    LAI Dong-ping    WANG Xiu-yu    ZHENG Dong-dan    GUO Run-min    SHEN Ning    CHEN Pei-xi    FENG Jian-qiang
Affiliation:1.Dept of Integrated,Gerontology Institute,Guandong Province People’s Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;2.Dept of Internal Medicine,Longnan Maternity and Child Health Care Hospital,Longnan Jiangxi 341700,China;3.Dept of Physiology,Zhongshan Medical College,Sun Yat-sen University,Guangzhou 510080,China;4.Dept of Cardiovasology,Region of Huangpu,the First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China)
Abstract:Aim To investigate the role of extracellular signal-regulated kinases 1/2(ERK1/2) pathway in doxorubicin(DOX)-induced injury in H9c2 cardiac cells(H9c2 cells).Methods H9c2 cells were treated with DOX to establish a model of cellular injury.PD-98059 was applied before exposure to DOX to inhibit ERK1/2 pathway.Cell viability,activation of ERK1/2,intracellular reactive oxygen species(ROS),mitochondrial membrane potential(MMP) and cystathionine-γ-lyase(CSE,a synthase of endogenous hydrogen sulfide) expression were tested.Results Exposure of H9c2 cells to 5 μmol·L-1 DOX for 1 to 6 h time-dependently induced the activation of ERK1/2.DOX at 5 μmol·L-1 had a damage effect on H9c2 cells,evidenced by decreases in cell viability,MMP and expression of CSE,and an increase in intracellular ROS level.Pretreatment with PD-98059 at 10 μmol·L-1 for 30 min before exposure of H9c2 cells to DOX significantly blocked DOX-induced cell injury,leading to increases in cell viability,MMP and CSE expression,and a decrease in ROS level.Conclusion ERK1/2 pathway is involved in H9c2 cell injury induced by DOX.
Keywords:doxorubicin  cardiac toxicity  H9c2 cardiac cells  reactive oxygen species  mitochondrial membrane potential  extracellular signal-regulated kinase 1/2
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号